Proposed Rules. DEPARTMENT OF JUSTICE
426 words·~2 min read·
/register/2000/08/23/00-21483A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 7020-02-U DEPARTMENT OF JUSTICE Drug Enforcement Administration Importation of Controlled Substances; Notice of Application Pursuant to Section 1008 of the Controlled Substances Import and Export Act (21 U.S.C. 958(i)), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a regulation under Section 1002(a) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with Section 1301.34 of Title 21, Code of Federal Regulations (CFR), notice is hereby given that on June 13, 2000, Applied Sciences Labs, Inc., a Division of Alltech Associates, Inc., 2701 Carolean Industrial Drive, P.O. Box 440, State College, Pennsylvania 16801, made application by renewal to the Drug Enforcement Administration to be registered as an importer of the basic classes of controlled substances listed below: Drug Schedule Heroin
(9200)I Cocaine
(9041)II Codeine
(9050)II Meperidine
(9230)II Methadone
(9250)II Morphine
(9300)II The firm plans to import these controlled substances for the manufacture of reference standards. Any manufacturer holding, or applying for, registration as a bulk manufacturer of these basic classes of controlled substances may file written comments on or objections to the application described above and may, at the same time, file a written request for a hearing on such application in accordance with 21 CFR 1301.43 in such form as prescribed by 21 CFR 1316.47. Any such comments, objections or requests for a hearing may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than September 22, 2000. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice at 40 FR 43745-46 (September 23, 1975), all applicants for registration to import the basic classes of any controlled substances in Schedule I or II are and will continue to be required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(a), (b), (c), (d), (e), and
(f)are satisfied. Dated: August 14, 2000. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 00-21483 Filed 8-22-00; 8:45 am]
Connectionstraces to 5
Citation graph
cites case law
Proposed Rules
DEPARTMENT OF JUSTICE
Cites 5Cited by 0 across 0 sources